KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Accumulated Expenses (2016 - 2025)

Petmed Express' Accumulated Expenses history spans 15 years, with the latest figure at $8.0 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 26.74% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $8.0 million, down 26.74%, while the annual FY2025 figure was $11.7 million, 65.88% up from the prior year.
  • Accumulated Expenses reached $8.0 million in Q4 2025 per PETS's latest filing, down from $10.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $11.7 million in Q1 2025 to a low of $1.5 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $6.8 million, with a median of $6.4 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: surged 201.05% in 2022, then plummeted 35.53% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $4.3 million in 2021, then dropped by 8.11% to $4.0 million in 2022, then soared by 39.66% to $5.6 million in 2023, then skyrocketed by 96.54% to $10.9 million in 2024, then dropped by 26.74% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Accumulated Expenses are $8.0 million (Q4 2025), $10.8 million (Q3 2025), and $10.9 million (Q2 2025).